Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Basal cell carcinoma arising within port-wine stain.
Marangi GF, Segreto F, Alessandri-Bonetti M, Coscarella G, Panasiti V, Vaienti L, Persichetti P. Marangi GF, et al. Among authors: coscarella g. Int J Dermatol. 2022 Jul;61(7):e269-e270. doi: 10.1111/ijd.15944. Epub 2021 Oct 10. Int J Dermatol. 2022. PMID: 34628637 No abstract available.
The Use of Adipose Tissue-Based Therapies on Facial Atrophic Postacne Vulgaris Scars.
Alessandri-Bonetti M, Coscarella G, Amendola F, Vaienti L, Persichetti P, Rubin PJ, Egro FM. Alessandri-Bonetti M, et al. Among authors: coscarella g. Facial Plast Surg Aesthet Med. 2023 Sep 26. doi: 10.1089/fpsam.2023.0103. Online ahead of print. Facial Plast Surg Aesthet Med. 2023. PMID: 37751219 No abstract available.
Regression of perianal warts after nonavalent human papillomavirus vaccination.
Dianzani C, Neagu N, Venuti A, Coscarella G, DE Franciscis B, Montini F, Zalaudek I, Conforti C. Dianzani C, et al. Among authors: coscarella g. Ital J Dermatol Venerol. 2023 Feb;158(1):62-63. doi: 10.23736/S2784-8671.22.07317-0. Ital J Dermatol Venerol. 2023. PMID: 36939504 No abstract available.
Efficacy of nonavalent human papillomavirus vaccine for recalcitrant warts.
Dianzani C, Neagu N, Venuti A, Coscarella G, DE Franciscis B, Montini F, Zalaudek I, Conforti C. Dianzani C, et al. Among authors: coscarella g. Ital J Dermatol Venerol. 2023 Feb;158(1):67-68. doi: 10.23736/S2784-8671.22.07380-7. Ital J Dermatol Venerol. 2023. PMID: 36939508 No abstract available.
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
Gori N, Ippoliti E, Ferrucci SM, Balato A, Ortoncelli M, Maurelli M, Galluzzo M, Munera Campos M, Seremet T, Di Nardo L, Antonelli F, Coscarella G, Conrad C, Carrascosa JM, Bianchi L, Argenziano G, Ribero S, Girolomoni G, Marzano AV, Chiricozzi A, Peris K; MEDaCoTRA Study Group. Gori N, et al. Among authors: coscarella g. J Eur Acad Dermatol Venereol. 2024 Feb 29. doi: 10.1111/jdv.19929. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38421043 No abstract available.
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa.
Calabrese L, Malvaso D, Coscarella G, Antonelli F, D'Amore A, Gori N, Rubegni P, Peris K, Chiricozzi A. Calabrese L, et al. Among authors: coscarella g. Biomolecules. 2024 Feb 1;14(2):175. doi: 10.3390/biom14020175. Biomolecules. 2024. PMID: 38397412 Free PMC article. Review.
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled.
Coscarella G, Falco GM, Palmisano G, Ippoliti E, De Luca E, Gori N, Di Nardo L, Caldarola G, De Simone C, Chiricozzi A, Peris K. Coscarella G, et al. Front Med (Lausanne). 2024 Jan 11;10:1295973. doi: 10.3389/fmed.2023.1295973. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38274451 Free PMC article.
43 results